Niagen Bioscience (NAGE)

• Market cap: $495M
• 1 day: 1.29%
• 5 days: -0.95%
• 1 month: -6.41%
• 3 months: -15.48%
• 6 months: -33.54%
• Year to date: 0.48%
• 1 year: 6.08%
• 5 years: 28.16%
• 10 years: 40.18%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 104